首页> 外文期刊>Cancer investigation >The Ratio KL-6 to SLX in Serum for Prediction of the Occurrence of Drug-Induced Interstitial Lung Disease in Lung Cancer Patients with Idiopathic Interstitial Pneumonias Receiving Chemotherapy
【24h】

The Ratio KL-6 to SLX in Serum for Prediction of the Occurrence of Drug-Induced Interstitial Lung Disease in Lung Cancer Patients with Idiopathic Interstitial Pneumonias Receiving Chemotherapy

机译:血清中的比率K1-6至SLX,用于预测药物诱导的肺癌患者特发性间质肺炎接受化疗的血清患者

获取原文
获取原文并翻译 | 示例
           

摘要

We retrospectively evaluated whether the ratio KL-6 to SLX in serum (K/S ratio) before chemotherapy was a predictor for the occurrence of drug-induced interstitial lung disease (D-ILD) in lung cancer patients with idiopathic interstitial pneumonias (IIPs). D-ILD occurred in 8 of 20 IIPs-positive cases and in 14 of 100 IIPs-negative cases (40vs. 14%, p = .015). In IIPs-positive cases, the high K/S ratio (>20) before first-line chemotherapy had a tendency to increase the risk of D-ILD (p = .085). Serum K/S ratio may be a useful predictor for the occurrence of D-ILD in lung cancer patients with IIPs.
机译:回顾性地评估化疗前的血清(k / s比率的SLX是否是血清(k / s比率)的比率是肺癌患者发作性间质肺炎(IIPS)的药物诱导的肺癌患者诱导的药物诱导的间质性肺病(D-ILD)的预测因素 。 D-ILD发生在20个IIPS阳性病例中的8个,14个IIPS阴性病例(40Vs。14%,P = .015)。 在IIPS阳性病例中,一线化疗前的高K / S比(> 20)具有增加D-ILD风险的趋势(p = .085)。 血清K / S比可以是IIPS肺癌患者D-ILD的发生的有用预测因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号